TG Therapeutics, Inc. (TGTX)

Last Closing Price: 64.88 (2026-11-19)

Debt to Capital Ratio (Quarterly)

Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)

TG Therapeutics, Inc. (TGTX) had Debt to Capital Ratio of 0.57 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$259.94M
$55.46M
$42.08M
$217.86M
$174.04M
$85.90M
$-12.04M
$73.86M
$73.86M
$55.46M
$55.46M
$55.46M
$55.46M
$85.90M
$86.05M
140.79M
155.93M
$0.39
$0.35
Balance Sheet Financials
$1.17B
--
$420.81M
$1.59B
$260.53M
$745.63M
$759.60M
$1.02B
$572.13M
$572.13M
$572.13M
151.16M
Cash Flow Statement Financials
$66.60M
$-7.50M
$291.17M
$80.49M
$430.75M
$350.26M
$72.53M
--
--
Fundamental Metrics & Ratios
4.50
--
--
Debt to Capital Ratio
0.57
1.30
83.81%
33.05%
33.05%
--
28.42%
21.34%
$65.97M
--
--
--
0.16
0.22
0.62
144.32
9.69%
9.69%
3.48%
4.21%
$3.78
$0.42
$0.43